In support of this contention, transgenic expression of LPA3 driven by the mouse mammary tumour virus promoter resulted in tumour development and metastasis similar to that observed in LPA1 or LPA2 transgenic mice (Liu et al, 2009). The gene discussed is LPAR3; the disease is neoplasm.